09.09.2019Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System

 

Press Release
26.04.2019Acutus Medical’s New Contact Mapping Software Receives CE Mark

 

Press Release
18.04.2019Arrakis Therapeutics Announces $75 Million Series B Financing To Advance a New Class of Small-Molecule Medicines Targeting RNA

Press Release
08.04.2019F2G appoints Dr Patrick Vink as Chairman

Press Release
02.04.2019Aura Biosciences Completes $40 Million Series D Financing

 

Press Release
22.02.2019Axonics® Granted Expanded CE Mark Label; First and Only Sacral Neuromodulation System Approved for Use with Full-Body MRI Scans

 

Press Release
05.10.2018Axonics Modulation Technologies, Inc. Announces Pricing of Initial Public Offering of Common Stock

Press Release
15.10.2018Aravive Biologics and Versartis Complete Merger

Press Release
29.08.2018KaNDy Therapeutics successfully raises £25 million in a Series C financing

Press Release
24.05.2018Iterum Therapeutics Announces Pricing of Initial Public Offering

Press Release